Ven Bio Partners LLC Harmony Biosciences Holdings, Inc. Transaction History

Ven Bio Partners LLC

$122 Million
Q4 2024

A detailed history of Ven Bio Partners LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ven Bio Partners LLC holds 539,194 shares of HRMY stock, worth $18.6 Million. This represents 15.27% of its overall portfolio holdings.

Number of Shares

539,194

Previous 614,594 12.27%

Holding current value

$18.6 Million

Previous $24.6 Million 24.44%

% of portfolio

15.27%

Previous 20.18%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$31.86 - $41.49 $2.4 Million - $3.13 Million	-75,400 Reduced 12.27%	539,194 $18.6 Million
Q3 2024 Nov 14, 2024	SELL	$30.0 - $39.95 $12.6 Million - $16.8 Million	-420,802 Reduced 40.64%	614,594 $24.6 Million
Q4 2022 Feb 14, 2023	SELL	$45.4 - $60.91 $4.1 Million - $5.5 Million	-90,277 Reduced 8.02%	1,035,396 $57.1 Million
Q3 2022 Nov 14, 2022	SELL	$42.06 - $55.45 $13.6 Million - $17.9 Million	-323,047 Reduced 22.3%	1,125,673 $49.9 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $3.21 Million - $4.99 Million	-95,764 Reduced 6.2%	1,448,720 $70.7 Million
Q1 2022 May 16, 2022	SELL	$33.14 - $51.13 $39.6 Million - $61.1 Million	-1,195,927 Reduced 43.64%	1,544,484 $75.1 Million
Q4 2021 Feb 14, 2022	SELL	$34.09 - $43.91 $11 Million - $14.2 Million	-322,783 Reduced 10.54%	2,740,411 $117 Million
Q3 2021 Nov 15, 2021	SELL	$25.68 - $38.61 $11.3 Million - $17 Million	-441,430 Reduced 12.6%	3,063,194 $117 Million
Q3 2020 Nov 16, 2020	BUY	$30.96 - $44.39 $109 Million - $156 Million	3,504,624 New	3,504,624 $119 Million

Others Institutions Holding HRMY

# of Institutions

255

Shares Held

46.6M

Call Options Held

119K

Put Options Held

50K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.04B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ven Bio Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ven Bio Partners LLC with notifications on news.

Account

Ven Bio Partners LLC Harmony Biosciences Holdings, Inc. Transaction History